These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 9758695)
1. Early phosphorylation events induced by DPIV/CD26-specific inhibitors. Kähne T; Neubert K; Faust J; Ansorge S Cell Immunol; 1998 Oct; 189(1):60-6. PubMed ID: 9758695 [TBL] [Abstract][Full Text] [Related]
2. Enzymatic activity of DPIV/CD26 is involved in PMA-induced hyperphosphorylation of p56lck. Kähne T; Neubert K; Ansorge S Immunol Lett; 1995 May; 46(1-2):189-93. PubMed ID: 7590918 [TBL] [Abstract][Full Text] [Related]
3. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. Torimoto Y; Dang NH; Vivier E; Tanaka T; Schlossman SF; Morimoto C J Immunol; 1991 Oct; 147(8):2514-7. PubMed ID: 1680916 [TBL] [Abstract][Full Text] [Related]
5. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. Ticchioni M; Deckert M; Mary F; Bernard G; Brown EJ; Bernard A J Immunol; 1997 Jan; 158(2):677-84. PubMed ID: 8992983 [TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1). Arndt M; Lendeckel U; Spiess A; Faust J; Neubert K; Reinhold D; Ansorge S Biochem Biophys Res Commun; 2000 Aug; 274(2):410-4. PubMed ID: 10913352 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD2-induced tyrosine phosphorylation of T cell polypeptides is independent of the PMA-induced modification of p56lck. Breithaupt TB; Rivera-Quiñones C; Molina C; Báez I; Eylar EH Cell Immunol; 1993 Mar; 147(1):139-47. PubMed ID: 8096437 [TBL] [Abstract][Full Text] [Related]
8. Chronic PMA treatment of Jurkat T lymphocytes results in decreased protein tyrosine phosphorylation and inhibition of CD3- but not Ti-dependent antibody-triggered Ca2+ signaling. Ahnadi CE; Giguère P; Gravel S; Gagné D; Goulet AC; Fülöp T; Payet MD; Dupuis G J Leukoc Biol; 2000 Aug; 68(2):293-300. PubMed ID: 10947075 [TBL] [Abstract][Full Text] [Related]
9. Calcium-induced p56(Lck) phosphorylation in human T lymphocytes via calmodulin dependent kinase. Franklin RA; Mcleod A; Robinson PJ Biochem Biophys Res Commun; 1999 Jun; 259(2):283-6. PubMed ID: 10362499 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986 [TBL] [Abstract][Full Text] [Related]
11. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Gaetaniello L; Fiore M; de Filippo S; Pozzi N; Tamasi S; Pignata C Hepatology; 1998 Apr; 27(4):934-42. PubMed ID: 9537431 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Kabouridis PS; Janzen J; Magee AL; Ley SC Eur J Immunol; 2000 Mar; 30(3):954-63. PubMed ID: 10741414 [TBL] [Abstract][Full Text] [Related]
13. IgD receptor-mediated signal transduction in T cells. Lakshmi Tamma SM; Wu Y; Toporovsky I; Lima V; Coico RF Cell Immunol; 2001 Feb; 207(2):110-7. PubMed ID: 11243700 [TBL] [Abstract][Full Text] [Related]
14. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease. Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345 [TBL] [Abstract][Full Text] [Related]
16. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. Dhennin-Duthille I; Masson M; Damiens E; Fillebeen C; Spik G; Mazurier J J Cell Biochem; 2000 Sep; 79(4):583-93. PubMed ID: 10996849 [TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346 [TBL] [Abstract][Full Text] [Related]
18. CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Ohnuma K; Yamochi T; Uchiyama M; Nishibashi K; Iwata S; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C Mol Cell Biol; 2005 Sep; 25(17):7743-57. PubMed ID: 16107720 [TBL] [Abstract][Full Text] [Related]
19. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. Kähne T; Kröning H; Thiel U; Ulmer AJ; Flad HD; Ansorge S Cell Immunol; 1996 May; 170(1):63-70. PubMed ID: 8660800 [TBL] [Abstract][Full Text] [Related]
20. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts. Jiménez-Periañez A; Ojeda G; Criado G; Sánchez A; Pini E; Madrenas J; Rojo JM; Portolés P J Leukoc Biol; 2005 Dec; 78(6):1386-96. PubMed ID: 16301324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]